{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:27:15Z","timestamp":1793683635076,"version":"4.5.1"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.fertnstert.2026.10.007","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:47:36Z","timestamp":1791906456000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fertility preservation in patients with genetic conditions predisposing to primary ovarian insufficiency"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2040-7207","authenticated-orcid":false,"given":"Emanuela","family":"Angelini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0914-7757","authenticated-orcid":false,"given":"Kutluk H.","family":"Oktay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2026.10.007_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/MED.0000000000000784","article-title":"Turner syndrome: fertility counselling in childhood and through the reproductive lifespan","volume":"30","author":"Bollig","year":"2023","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jpag.2015.10.011","article-title":"Fertility preservation in women with Turner syndrome: a comprehensive review and practical guidelines","volume":"29","author":"Oktay","year":"2016","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/molehr\/gag031","article-title":"Accelerated germ cell apoptosis in sex chromosome aneuploid fetal human gonads","volume":"9","author":"Modi","year":"2003","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib4","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.fertnstert.2003.12.011","article-title":"Number of ovarian follicles in human fetuses with the 45,X karyotype","volume":"81","author":"Reynaud","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1210\/jc.2008-0708","article-title":"Fertility preservation in girls with Turner syndrome: prognostic signs of the presence of ovarian follicles","volume":"94","author":"Borgstr\u00f6m","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/cen.14076","article-title":"Fertility preservation in Turner syndrome: karyotype does not predict ovarian response to stimulation","volume":"91","author":"Vergier","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib7","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1093\/humrep\/deaa197","article-title":"Added value of buccal cell FISH analysis in the diagnosis and management of Turner syndrome","volume":"35","author":"Graff","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/humrep\/deaf249","article-title":"Fertility preservation and counselling in prepubertal and pubertal girls with Turner syndrome","volume":"41","author":"Sage","year":"2026","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib9","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1093\/humrep\/dez135","article-title":"Ovarian follicles of young patients with Turner's syndrome contain normal oocytes but monosomic 45,X granulosa cells","volume":"34","author":"Peek","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib10","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/humrep\/dew012","article-title":"Spontaneous fertility and pregnancy outcomes amongst 480 women with Turner syndrome","volume":"31","author":"Bernard","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.fertnstert.2020.03.002","article-title":"Fertility issues and pregnancy outcomes in Turner syndrome","volume":"114","author":"Calanchini","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.fertnstert.2015.11.042","article-title":"Fertility preservation in Turner syndrome","volume":"105","author":"Grynberg","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.fertnstert.2025.12.001","article-title":"Fertility preservation in patients with medical indications: a committee opinion","volume":"125","year":"2026","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib14","doi-asserted-by":"crossref","first-page":"E1030","DOI":"10.1210\/jc.2015-1621","article-title":"AMH as predictor of premature ovarian insufficiency: a longitudinal study of 120 Turner syndrome patients","volume":"100","author":"Lunding","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/6976389","article-title":"The cut-off value of serum anti-M\u00fcllerian hormone levels for the diagnosis of Turner syndrome with spontaneous puberty","volume":"2023","author":"Wang","year":"2023","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib16","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.fertnstert.2023.08.004","article-title":"Turner fertility trial: fertility preservation in young girls with Turner syndrome by freezing ovarian cortex tissue\u2014a prospective intervention study","volume":"120","author":"Nadesapillai","year":"2023","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib17","doi-asserted-by":"crossref","first-page":"6502","DOI":"10.3390\/jcm12206502","article-title":"Reproductive outcomes of women with Turner syndrome undergoing oocyte vitrification: a retrospective multicenter cohort study","volume":"12","author":"Nadesapillai","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jpag.2022.03.003","article-title":"Gonadectomy in individuals with Turner syndrome and Y chromosome material: fertility considerations","volume":"35","author":"Dowlut-McElroy","year":"2022","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib19","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jpag.2026.05.014","article-title":"Functional ovarian tissue in a child with mosaic Turner syndrome and Y chromosome material: case report","volume":"39","author":"Hwu","year":"2026","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2026.1793595","article-title":"Balancing oncologic risk and fertility potential: a single-center study on Turner syndrome patients with Y chromosome material","volume":"17","author":"Shuai","year":"2026","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib21","doi-asserted-by":"crossref","first-page":"753.e15","DOI":"10.1016\/j.fertnstert.2010.01.044","article-title":"Fertility preservation by ovarian stimulation and oocyte cryopreservation in a 14-year-old adolescent with Turner syndrome mosaicism and impending premature ovarian failure","volume":"94","author":"Oktay","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.fertnstert.2018.11.010","article-title":"Outcome of ovarian stimulation for oocyte cryopreservation in women with Turner syndrome","volume":"111","author":"Talaulikar","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib23","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1080\/09513590.2020.1822805","article-title":"DuoStim: a new option for fertility preservation for a woman with Turner syndrome","volume":"36","author":"Ito","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib24","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10815-022-02420-4","article-title":"First live birth after fertility preservation using vitrification of oocytes in a woman with mosaic Turner syndrome","volume":"39","author":"Strypstein","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib25","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.fertnstert.2020.03.009","article-title":"Bypassing physiological puberty, a novel procedure of oocyte cryopreservation at age 7: a case report and review of the literature","volume":"114","author":"Azem","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib26","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.fertnstert.2024.04.013","article-title":"The use of preimplantation genetic testing for aneuploidy: a committee opinion","volume":"122","year":"2024","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib27","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/humrep\/deaa007","article-title":"International consensus: ovarian tissue cryopreservation in young Turner syndrome patients: outcomes of an ethical Delphi study including 55 experts from 16 different countries","volume":"35","author":"Schleedoorn","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib28","first-page":"3618","article-title":"Follicles are found in the ovaries of adolescent girls with Turner's syndrome","volume":"87","author":"Hreinsson","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/humupd\/dmae005","article-title":"Navigating fertility dilemmas across the lifespan in girls with Turner syndrome\u2014a scoping review","volume":"30","author":"van der Coelen","year":"2024","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib30","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.fertnstert.2019.02.003","article-title":"Characterization of follicles in girls and young women with Turner syndrome who underwent ovarian tissue cryopreservation","volume":"111","author":"Mamsen","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib31","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10815-021-02067-7","article-title":"Fertility preservation for genetic diseases leading to premature ovarian insufficiency (POI)","volume":"38","author":"La Marca","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1135249","article-title":"Trends and outcomes of fertility preservation for girls, adolescents and young adults with Turner syndrome: a prospective cohort study","volume":"14","author":"Rodriguez-Wallberg","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib33","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1007\/s10815-023-02905-w","article-title":"Clinical pregnancy in Turner syndrome following re-implantation of cryopreserved ovarian cortex","volume":"40","author":"Dunlop","year":"2023","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib34","series-title":"Principles and practice of ovarian tissue cryopreservation and transplantation","first-page":"61","article-title":"Oocyte retrieval and in vitro maturation from the harvested tissue before cryopreservation","author":"Sugishita","year":"2022"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib35","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/humrep\/dem307","article-title":"Cryopreservation of ovarian tissue and in vitro matured oocytes in a female with mosaic Turner syndrome: case report","volume":"23","author":"Huang","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/humupd\/dmaf026","article-title":"Female fertility preservation: 25 years of progress, expanding indications and future prospects","volume":"32","author":"Sonmezer","year":"2026","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib37","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.fertnstert.2024.06.003","article-title":"Maternal cardiovascular morbidity and mortality associated with pregnancy in individuals with Turner syndrome: a committee opinion","volume":"122","year":"2024","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib38","doi-asserted-by":"crossref","DOI":"10.1161\/HCG.0000000000000048","article-title":"Cardiovascular health in Turner syndrome: a scientific statement from the American Heart Association","volume":"11","author":"Silberbach","year":"2018","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib39","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2006.09.004","article-title":"The FMR1 premutation and reproduction","volume":"87","author":"Wittenberger","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib40","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/GME.0000000000000658","article-title":"Reproductive and gynecologic care of women with fragile X primary ovarian insufficiency (FXPOI)","volume":"23","author":"Hipp","year":"2016","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ando.2024.04.004","article-title":"Ovarian reserve in patients with FMR1 gene premutation and the role of fertility preservation","volume":"85","author":"Le Poulennec","year":"2024","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib42","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fnmol.2017.00290","article-title":"Fragile X-associated diminished ovarian reserve and primary ovarian insufficiency from molecular mechanisms to clinical manifestations","volume":"10","author":"Man","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib43","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/s41436-021-01177-y","article-title":"Refining the risk for fragile X-associated primary ovarian insufficiency (FXPOI) by FMR1 CGG repeat size","volume":"23","author":"Allen","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib44","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1210\/clinem\/dgac536","article-title":"Granulosa cell dysfunction is associated with diminished ovarian response in FMR1 premutation carriers","volume":"107","author":"Boustanai","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib45","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/humrep\/den050","article-title":"Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study","volume":"23","author":"Rohr","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib46","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1093\/humrep\/der146","article-title":"Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriers","volume":"26","author":"Spath","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib47","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/humrep\/dex090","article-title":"The ovarian response in fragile X patients and premutation carriers undergoing IVF-PGD: reappraisal","volume":"32","author":"Avraham","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib48","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3390\/genes15081008","article-title":"Prevalence of the FMR1 gene premutation in young women with a diminished ovarian reserve included in an IVF program: implications for clinical practice","volume":"15","author":"Agust\u00ed","year":"2024","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib49","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/13697137.2024.2408922","article-title":"Evidence-based guideline: premature ovarian insufficiency","volume":"27","author":"Panay","year":"2024","journal-title":"Climacteric"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib50","series-title":"GeneReviews\u00ae","first-page":"1993","article-title":"FMR1 disorders","author":"Hunter","year":"1998"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib51","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.fertnstert.2023.03.003","article-title":"Indications and management of preimplantation genetic testing for monogenic conditions: a committee opinion","volume":"120","year":"2023","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib52","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.rbmo.2018.11.009","article-title":"Does the FMR1 gene affect IVF success?","volume":"38","author":"Pastore","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib53","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s10815-020-01809-3","article-title":"Are ovarian response and pregnancy rates similar in selected FMR1 premutated and mutated patients undergoing preimplantation genetic testing?","volume":"37","author":"Ranisavljevic","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib54","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/gim.2014.106","article-title":"Fragile X full mutation expansions are inhibited by one or more AGG interruptions in premutation carriers","volume":"17","author":"Nolin","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib55","series-title":"GeneReviews\u00ae","first-page":"1993","article-title":"Classic galactosemia and clinical variant galactosemia","author":"Berry","year":"2000"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib56","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1530\/RAF-21-0014","article-title":"Pathophysiology and management of classic galactosemic primary ovarian insufficiency","volume":"2","author":"Hagen-Lillevik","year":"2021","journal-title":"Reprod Fertil"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib57","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s40618-024-02527-8","article-title":"Primary ovarian insufficiency in classic galactosemia: a systematic review","volume":"48","author":"Candela","year":"2025","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib58","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41598-017-00159-y","article-title":"Galactose and its metabolites deteriorate metaphase II mouse oocyte quality and subsequent embryo development by disrupting the spindle structure","volume":"7","author":"Thakur","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib59","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.fertnstert.2008.04.060","article-title":"Biomarkers of ovarian function in girls and women with classic galactosemia","volume":"92","author":"Sanders","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib60","doi-asserted-by":"crossref","first-page":"E1257","DOI":"10.1210\/jc.2013-1374","article-title":"Modifiers of ovarian function in girls and women with classic galactosemia","volume":"98","author":"Spencer","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib61","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/humupd\/dmac041","article-title":"The hypergonadotropic hypogonadism conundrum of classic galactosemia","volume":"29","author":"Derks","year":"2023","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib62","doi-asserted-by":"crossref","first-page":"1293.e13","DOI":"10.1016\/j.fertnstert.2008.12.031","article-title":"Pregnancy in classic galactosemia despite undetectable anti-M\u00fcllerian hormone","volume":"91","author":"Gubbels","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib63","doi-asserted-by":"crossref","first-page":"290.e1","DOI":"10.1016\/j.fertnstert.2010.06.014","article-title":"Ovarian tissue cryopreservation and subsequent spontaneous pregnancies in a patient with classic galactosemia","volume":"95","author":"Forges","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib64","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/09513590.2021.1998437","article-title":"Two consecutive pregnancies in a patient with premature ovarian insufficiency in the course of classic galactosemia and a review of the literature","volume":"38","author":"Kruszewska","year":"2022","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib65","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.fertnstert.2017.05.013","article-title":"Fertility in adult women with classic galactosemia and primary ovarian insufficiency","volume":"108","author":"van Erven","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib66","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1530\/EC-21-0013","article-title":"Puberty and fertility in classic galactosemia","volume":"10","author":"Flechtner","year":"2021","journal-title":"Endocr Connect"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib67","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1750-1172-8-107","article-title":"Fertility preservation in female classic galactosemia patients","volume":"8","author":"van Erven","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib68","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s10815-018-1209-2","article-title":"Cryopreservation of ovarian tissue may be considered in young girls with galactosemia","volume":"35","author":"Mamsen","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib69","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.fertnstert.2022.08.005","article-title":"Laparoscopic ovarian tissue harvesting for cryopreservation from a child with galactosemia","volume":"118","author":"Vash-Margita","year":"2022","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib70","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.fertnstert.2024.05.146","article-title":"Ovarian histology in children with classic galactosemia and correlation with endocrine and metabolic markers","volume":"122","author":"Badger","year":"2024","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70043","article-title":"Single-nucleus and spatial transcriptomics of paediatric ovary: molecular insights into the dysregulated signalling pathways underlying premature ovarian insufficiency in classic galactosemia","volume":"14","author":"Kavarthapu","year":"2024","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib72","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.tem.2018.03.010","article-title":"Advances in the molecular pathophysiology, genetics, and treatment of primary ovarian insufficiency","volume":"29","author":"Huhtaniemi","year":"2018","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib73","article-title":"Genetics of primary ovarian insufficiency in the next-generation sequencing era","volume":"4","author":"Fran\u00e7a","year":"2019","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104246","article-title":"Genetic landscape of a large cohort of primary ovarian insufficiency: new genes and pathways and implications for personalized medicine","volume":"84","author":"Heddar","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1464803","article-title":"Primary ovarian insufficiency: update on clinical and genetic findings","volume":"15","author":"Federici","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib76","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.fertnstert.2022.05.024","article-title":"Genetics of primary ovarian insufficiency: a careful step-by-step approach based on solid foundations to bring new knowledge","volume":"118","author":"Heddar","year":"2022","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib77","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41591-022-02194-3","article-title":"Landscape of pathogenic mutations in premature ovarian insufficiency","volume":"29","author":"Ke","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib78","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13048-023-01104-6","article-title":"Next-generation sequencing of 500 POI patients identified novel responsible monogenic and oligogenic variants","volume":"16","author":"Luo","year":"2023","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib79","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ajhg.2014.11.002","article-title":"MCM9 mutations are associated with ovarian failure, short stature, and chromosomal instability","volume":"95","author":"Wood-Trageser","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib80","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1172\/JCI78473","article-title":"Exome sequencing reveals MCM8 mutation underlies ovarian failure and chromosomal instability","volume":"125","author":"AlAsiri","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib81","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1056\/NEJMc1310150","article-title":"Primary Ovarian Insufficiency Collaboration. Mutations in HFM1 in recessive primary ovarian insufficiency","volume":"370","author":"Wang","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib82","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ejhg.2015.107","article-title":"STAG3 truncating variant as the cause of primary ovarian insufficiency","volume":"24","author":"Le Quesne Stabej","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib83","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/jmedgenet-2019-106672","article-title":"Homozygous hypomorphic BRCA2 variant in primary ovarian insufficiency without cancer or Fanconi anaemia trait","volume":"58","author":"Caburet","year":"2020","journal-title":"J Med Genet"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib84","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/s42003-025-08426-9","article-title":"Biallelic BRCA2 variants induce premature ovarian insufficiency by impaired meiotic homologous recombination","volume":"8","author":"Wu","year":"2025","journal-title":"Commun Biol"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib85","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1038\/s41418-022-01021-z","article-title":"A truncating variant of RAD51B associated with primary ovarian insufficiency provides insights into its meiotic and somatic functions","volume":"29","author":"Franca","year":"2022","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib86","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41525-021-00242-4","article-title":"MCM9 is associated with germline predisposition to early\u2014onset cancer-clinical evidence","volume":"6","author":"Goldberg","year":"2021","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib87","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/humu.23988","article-title":"Fundamental role of BMP15 in human ovarian folliculogenesis revealed by null and missense mutations associated with primary ovarian insufficiency","volume":"41","author":"Rossetti","year":"2020","journal-title":"Hum Mutat"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib88","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10815-023-02981-y","article-title":"NOBOX gene variants in premature ovarian insufficiency: ethnicity-dependent insights","volume":"41","author":"Jordan","year":"2024","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.148734","article-title":"Revisiting GDF9 variants in primary ovarian insufficiency: a shift from dominant to recessive pathogenicity?","volume":"927","author":"Jordan","year":"2024","journal-title":"Gene"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib90","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/humrep\/deaf058","article-title":"Reclassifying NOBOX variants in primary ovarian insufficiency cases with a corrected gene model and a novel quantitative framework","volume":"40","author":"Veitia","year":"2025","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.148946","article-title":"Association of FOXL2 and ERCC6 variants with premature ovarian insufficiency and their potential use in clinical IVF guidance","volume":"933","author":"Gu","year":"2025","journal-title":"Gene"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2025.102023","article-title":"Broader impact and outcome of human NR5A1\/SF1 variants","volume":"39","author":"Kouri","year":"2025","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib93","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa0806228","article-title":"Mutations in NR5A1 associated with ovarian insufficiency","volume":"360","author":"Louren\u00e7o","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib94","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.1073\/pnas.1103471108","article-title":"Mutations in mitochondrial histidyl tRNA synthetase HARS2 cause ovarian dysgenesis and sensorineural hearing loss of Perrault syndrome","volume":"108","author":"Pierce","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib95","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/cge.12867","article-title":"Mutations of SGO2 and CLDN14 collectively cause coincidental Perrault syndrome","volume":"91","author":"Faridi","year":"2017","journal-title":"Clin Genet"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib96","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00439-021-02319-7","article-title":"New insights into Perrault syndrome, a clinically and genetically heterogeneous disorder","volume":"141","author":"Faridi","year":"2022","journal-title":"Hum Genet"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib97","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejogrb.2024.05.041","article-title":"A homozygous mutation of TWNK identified in premature ovarian insufficiency warns of late-onset Perrault syndrome","volume":"299","author":"Chang","year":"2024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib98","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1210\/clinem\/dgaf124","article-title":"A tiered approach to exome sequencing analysis in early-onset primary ovarian insufficiency","volume":"110","author":"McGlacken-Byrne","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib99","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.fertnstert.2019.07.1349","article-title":"Reproductive and hormonal considerations in women at increased risk for hereditary gynecologic cancers: society of gynecologic oncology and American Society for Reproductive Medicine Evidence-Based Review","volume":"112","author":"Chen","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib100","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/ijgc-2020-002071","article-title":"Fertility preservation in patients with BRCA mutations or Lynch syndrome","volume":"31","author":"Corrado","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib101","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2009.24.2057","article-title":"Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast\/ovarian cancer risks","volume":"28","author":"Oktay","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib102","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004925","article-title":"Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans","volume":"5","author":"Titus","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib103","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/humupd\/dmz043","article-title":"BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging","volume":"26","author":"Turan","year":"2020","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib104","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.fertnstert.2017.12.004","article-title":"BRCA mutations and reproduction","volume":"109","author":"Daum","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib105","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s43856-025-00788-9","article-title":"Reduced reproductive potential in young healthy women with hereditary breast and\/or ovarian cancer syndrome","volume":"5","author":"Sighinolfi","year":"2025","journal-title":"Commun Med (Lond)"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib106","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1095\/biolreprod.115.132290","article-title":"BRCA mutations, DNA repair deficiency, and ovarian aging","volume":"93","author":"Oktay","year":"2015","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib107","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/annonc\/mdx639","article-title":"Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients","volume":"29","author":"Lambertini","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib108","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.fertnstert.2020.01.033","article-title":"Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency","volume":"113","author":"Oktay","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib109","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.fertnstert.2015.07.1162","article-title":"BRCA mutation carriers show normal ovarian response in in vitro fertilization cycles","volume":"104","author":"Shapira","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib110","first-page":"930","article-title":"Impact of breast cancer and germline BRCA pathogenic variants on fertility preservation in young women","volume":"13","author":"Prokurotaite","year":"2023","journal-title":"Life (Basel)"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib111","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.fertnstert.2017.03.018","article-title":"Antim\u00fcllerian hormone levels are lower in BRCA2 mutation carriers","volume":"107","author":"Johnson","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib112","article-title":"Reproductive outcomes in women with BRCA 1\/2 germline mutations: a retrospective observational study and literature review","volume":"19","author":"Dellino","year":"2024","journal-title":"Open Med (Wars)"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib113","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1933719117728800","article-title":"Ovarian stimulation in patients with cancer: impact of letrozole and BRCA mutations on fertility preservation cycle outcomes","volume":"25","author":"Turan","year":"2018","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib114","article-title":"Rare coding variants in DNA damage repair genes associated with timing of natural menopause","volume":"3","author":"Ward","year":"2021","journal-title":"HGG Adv"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib115","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41586-024-07931-x","article-title":"Genetic links between ovarian ageing, cancer risk and de novo mutation rates","volume":"633","author":"Stankovic","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib116","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/jmg-2025-111339","article-title":"Later age of natural menopause among women with the pathogenic CHEK2 c.1100delC variant: a validation study","volume":"63","author":"Schreurs","year":"2026","journal-title":"J Med Genet"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib117","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1126\/science.1247671","article-title":"Reversal of female infertility by Chk2 ablation reveals the oocyte DNA damage checkpoint pathway","volume":"343","author":"Bolcun-Filas","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib118","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s10815-022-02486-0","article-title":"Hereditary breast cancer and fertility preservation outcomes","volume":"39","author":"Arab","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib119","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/humupd\/dmv036","article-title":"Genetics of primary ovarian insufficiency: new developments and opportunities","volume":"21","author":"Qin","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib120","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyag212","article-title":"Women's health across the reproductive lifespan in women with germline TP53 pathogenic variants: a clinical perspective","volume":"31","author":"Halpern","year":"2026","journal-title":"Oncologist"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib121","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/jmg-2022-108898","article-title":"UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2","volume":"60","author":"Hanson","year":"2023","journal-title":"J Med Genet"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib122","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1200\/JCO-24-02782","article-title":"Fertility preservation in people with cancer: ASCO guideline update","volume":"43","author":"Su","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib123","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.fertnstert.2026.02.025","article-title":"Preimplantation genetic testing for BReast CAncer gene 1 and risk-reducing surgery is more effective at age 35 than age 40","volume":"125","author":"Hunkler","year":"2026","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib124","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ygyno.2024.03.025","article-title":"Walking the tightrope: fertility preservation among hereditary breast and ovarian cancer syndrome previvors","volume":"186","author":"Holtzman","year":"2024","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib125","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41431-025-02007-4","article-title":"ERN GENTURIS guideline on counselling on reproductive options for individuals with a cancer predisposition syndrome (including genturis)","volume":"34","author":"Farschtschi","year":"2026","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib126","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/GCO.0000000000001038","article-title":"Fertility counseling for patients with hereditary breast and ovarian cancer syndrome","volume":"37","author":"Safi","year":"2025","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib127","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.3390\/genes14112069","article-title":"Public awareness and acceptability of PGT-M in cancer predisposition syndromes","volume":"14","author":"Calosci","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib128","article-title":"Normal ovarian reserve during long-term osimertinib therapy in a patient with Li-Fraumeni syndrome: a case report and literature review","volume":"18","author":"Salih","year":"2026","journal-title":"Cureus"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib129","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1200\/JCO.2005.05.037","article-title":"Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation","volume":"23","author":"Oktay","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib130","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.2005.04.011","article-title":"Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation","volume":"23","author":"Oktay","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib131","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1210\/jc.2015-3878","article-title":"Long-term safety of letrozole and gonadotropin stimulation for fertility preservation in women with breast cancer","volume":"101","author":"Kim","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib132","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/humrep\/dex027","article-title":"The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review","volume":"32","author":"Rodgers","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib133","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00404-020-05690-4","article-title":"Use of fertility treatments in BRCA1\/2 mutation carriers and risk for ovarian and breast cancer: a systematic review","volume":"302","author":"Huber","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib134","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pky078","article-title":"The influence of number and timing of pregnancies on breast cancer risk for women with BRCA1 or BRCA2 mutations","volume":"2","author":"Terry","year":"2018","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.fertnstert.2026.10.007_bib135","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1007\/s10815-023-02954-1","article-title":"Attitude of BRCA1\/2 mutation carriers towards fertility preservation, family planning and preimplantation genetic testing for primary prevention of breast and ovarian cancer in the next generation","volume":"40","author":"Nahshon","year":"2023","journal-title":"J Assist Reprod Genet"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028226018145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028226018145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:45:47Z","timestamp":1793681147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028226018145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":135,"alternative-id":["S0015028226018145"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2026.10.007","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fertility preservation in patients with genetic conditions predisposing to primary ovarian insufficiency","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2026.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92026 Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine","name":"copyright","label":"Copyright"}]}}